Memantine Hydrochloride Capsule, Extended Release
Product Images NDC 69680-162

9 FDA label images from Vitruvias Therapeutics, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 69680-162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vitruvias Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of memantine hydrochloride, showing a bicyclic amine with methyl substituents and the associated hydrochloride group.*
FDA Label Image

Figure 1: Time Course Of The Change From Baseline In Sib Score For Patients Completing 24 Weeks Of Treatment. (Figure 1)

Figure 1: Time Course Of The Change From Baseline In Sib Score For Patients Completing 24 Weeks Of Treatment. (Figure 1)
A line graph showing the mean (± SEM) change from baseline in SIB score over 24 weeks of treatment comparing Memantine Extended Release Capsules 28 mg to Placebo, both with AChEI. The graph shows clinical improvement above the baseline and clinical decline below, with data points at weeks 0, 4, 8, 12, 20, and 24. Memantine shows sustained higher scores over placebo.*
FDA Label Image

Figure 2: Cumulative Percentage Of Patients Completing 24 Weeks Of Double-blind Treatment With Specified Changes From Baseline In Sib Scores. (Figure 2)

Figure 2: Cumulative Percentage Of Patients Completing 24 Weeks Of Double-blind Treatment With Specified Changes From Baseline In Sib Scores. (Figure 2)
A cumulative percentage plot comparing Memantine Extended Release Capsules 28 mg combined with AChEI to a placebo with AChEI. The horizontal axis shows SIB change from baseline, and the vertical axis shows the cumulative percentage of patients, illustrating response distribution between treatment and placebo groups.*
FDA Label Image

Figure 3: Time Course Of The Cibic-plus Score For Patients Completing 24 Weeks Of Treatment. (Figure 3)

Figure 3: Time Course Of The Cibic-plus Score For Patients Completing 24 Weeks Of Treatment. (Figure 3)
A line graph comparing the mean CIBIC-Plus scores over 24 weeks of treatment for Memantine Extended Release Capsules 28 mg versus placebo in combination with AChEI. The x-axis shows weeks of treatment, and the y-axis shows mean scores with standard error. Scores indicate clinical improvement or decline, with Memantine showing stable improvement and placebo showing decline over time.*
FDA Label Image

Figure 4: Distribution Of Cibic-plus Ratings At Week 24. (Figure 4)

Figure 4: Distribution Of Cibic-plus Ratings At Week 24. (Figure 4)
A bar chart comparing the percentage of patients across different CIBIC Plus Rating categories between Memantine Extended Release Capsules 28 mg/AChEI and Placebo/AChEI groups. Categories include marked improvement, moderate improvement, minimal improvement, no change, minimal worsening, moderate worsening, and marked worsening. The chart visually represents patient response distribution for these treatments.*
FDA Label Image

Ndc 69680-161-30 30 Capsules Rx Only Once-daily Memantine HCl Extended-release Capsules 7 mg (7 mg)

Ndc 69680-161-30 30 Capsules Rx Only Once-daily Memantine HCl Extended-release Capsules 7 mg (7 mg)
Label for Memantine Hydrochloride Extended-Release Capsules, 7 mg dosage form, containing 30 capsules per package. The label states once daily dosing and prescription-only status. It is labeled by Vitruvias Therapeutics, Inc., with manufacturing by Xiamen LP Pharmaceutical Co., Ltd., China. Storage instructions and barcode are also included on the label.*
FDA Label Image

Ndc 69680-162-30 30 Capsules Rx Only Once-daily Memantine HCl Extended-release Capsules 14 mg (14 mg)

Ndc 69680-162-30 30 Capsules Rx Only Once-daily Memantine HCl Extended-release Capsules 14 mg (14 mg)
Label for Memantine Hydrochloride Extended-Release Capsules 14 mg, in a 30-capsule package. The product is labeled for once daily oral use, prescription only. Manufactured by Xiamen LP Pharmaceutical Co., Ltd. and distributed by Vitruvias Therapeutics, Inc. The label includes storage instructions and a barcode with a QR code.*
FDA Label Image

Ndc 69680-163-30 30 Capsules Rx Only Once-daily Memantine HCl Extended-release Capsules 21 mg (21 mg)

Ndc 69680-163-30 30 Capsules Rx Only Once-daily Memantine HCl Extended-release Capsules 21 mg (21 mg)
Label for Memantine Hydrochloride 21 mg extended-release oral capsules by Vitruvias Therapeutics, Inc. The label indicates a 30-capsule package with instructions to take once daily. It also includes storage recommendations, manufacturer and distributor information, and a barcode with a QR code containing product identifiers.*
FDA Label Image

Ndc 69680-164-30 30 Capsules Rx Only Once-daily Memantine HCl Extended-release Capsules 28 mg (28 mg)

Ndc 69680-164-30 30 Capsules Rx Only Once-daily Memantine HCl Extended-release Capsules 28 mg (28 mg)
Packaging label for Memantine Hydrochloride Extended-Release Capsules, 28 mg strength, oral dosage form. The label indicates it is for once-daily use and prescription only. The product is manufactured by Xiamen LP Pharmaceutical Co., Ltd., China, and distributed by Vitruvias Therapeutics, Inc., Auburn, Alabama. The label includes storage instructions and legal barcode information with NDC number 69680-164-30 for a 30-capsule package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.